Swedish Research Council allocates 25 million SEK to platform for antibiotics development
The Swedish Research Council has decided to allocate 26 million SEK to fund ENABLE-2, a platform for developing antibiotics at Uppsala University, during 2021–2022.
The platform opened on 4 October for new applications. The research to be funded via the platform shall relate to molecules that may be candidates for antibacterial medicines. With support from Vinnova, companies may also apply to use the platform.
Pdf / Printout
MORE WITHIN THE SAME SUBJECT AREA
Published 14 November 2022
World Antimicrobial Awareness Week runs from 18 to 24 November this year. The purpose of the week is to highlight the global challenge of antibiotic resistance and antimicrobial resistance.
Published 31 January 2022
On 3 February, JPIAMR organises an international conference to discuss and shape a new partnership with a so-called "One Health" perspective. The conference is aimed at the research community, research policy actors as well as the public and private ...
Published 18 November 2021
To safeguard the world’s supply of effective medicines, we need large resources for research and innovation, broad-based global collaboration and clear leadership. Sweden plays a leading role in the international efforts against antibiotic resistance...